A new round of pharmaceutical investment campaign will start the three-line Nuggets concept stock

　　According to the Shanghai Stock Exchange, as of September 15, this year, the A-share market in the case of biopharmaceutical investment and mergers and acquisitions as high as 89, a sharp increase of 128 percent over the same period last year, including medical device-related areas of 35 mergers and acquisitions, accounting for nearly 40% of the total number of pharmaceutical mergers and acquisitions And from the recently held medical and health industry investment summit forum was informed that innovative drug research and development, medical devices and mobile medical three sub-sectors will lead a new round of pharmaceutical investment campaign
this year, the pharmaceutical industry investment and mergers and acquisitions "firepower open", has become a popular area of the pursuit of various capital Recently, in such as well-known PE and listed companies at home and abroad, Hengrui Pharmaceutical 、、、、 talk about the most fashionable health care industry investment, non-mobile medical is not a non-mobile medical At a time when the market is weighing the short-term benefits and long-term benefits of investing in mobile healthcare, PE and pharmaceutical industry experts have pointed the way for mobile healthcare investment in the 2014 peak investment theory National Center for Drug Policy and Pharmaceutical Industry Economic Research, Xuan Jianwei pointed out that China's health care services are very inefficient, mobile medical intervention can help doctors to change this inefficient situation "Mobile medicine can't replace doctors, but helping doctors practice medicine, making them better, patients recovering faster, and society spending less on resources is the key to mobile medicine." The greatest goal of mobile medicine is to improve the standard of health services, secondly to better manage health chronic diseases, and finally because of the large amount of data, you can also provide a large database, so as to continuously improve optimization According to the analysis, Tencent's recent stake in Lilac Garden has caused great concern, and similar business stocks are also worthy of attention: Shangrong Medical .